OS Therapies Inc. (OSTX) Short-Term Debt to Equity

OS Therapies Incorporated (OSTX) management focuses on developing immunotherapeutic methods to combat rare pediatric bone tumors. This chart illustrates the asset's price action with the 0.00 metric. The business relies on bacterial vectors to activate the body's defenses when chemotherapy proves ineffective. Meanwhile, the company minimizes its environmental impact through laboratory waste disposal and paper recycling.

Professional asset selection requires an analysis of the liability structure to assess the issuer's financial stability. The ratio of loans with a maturity of more than one year to equity, reflected in the short-term debt-to-equity ratio, determines the balance between leverage and bankruptcy risk, which is critical for OS Therapies Incorporated (OSTX) when financing costly clinical trials of anti-cancer drugs.